Company / Working Capital
Xilio Therapeutics, Inc. Working Capital History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$88.8M
FY2025
5-year range
$33.0M / $88.8M
FY2024-FY2025
Trend
+169.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$89M in FY2025.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital increased 169.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.71 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $88.8M | +169.2% |
| FY2024 | $33.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026